What is Treeline Biosciences worth?
$1.3Blast known valuation
Treeline Biosciences last raised $200.1M in its Later Stage VC (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Treeline Biosciences
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Later Stage VC | $200.1M | ▮ | ▮ |
| Oct 2024 | Later Stage VC | $421.8M | ▮ | ▮ |
How Treeline Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Treeline Biosciences, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Treeline Biosciences worth?
- Treeline Biosciences's implied valuation is $1.3B, based on the PA Mark composite price of about $8 per share as of Sep 2026.
- How much has Treeline Biosciences raised?
- Treeline Biosciences has raised $1.1B in total funding across 2 recorded rounds.
- When did Treeline Biosciences last raise?
- Treeline Biosciences last raised in Aug 2025 (Later Stage VC), raising $200.1M.